Windward Bio Begins Global Phase 2 Asthma Trial for WIN378
23 Jul 2025 //
GLOBENEWSWIRE
Windward Bio Begins Global Phase 2 Asthma Trial of SKB378/WIN378
23 Jul 2025 //
PR NEWSWIRE
Windward Bio Launches With $200M Series A For Anti-TSLP Antibody
10 Jan 2025 //
GLOBENEWSWIRE
Novo Invests $200M for Windward Bio`s Asthma and COPD Treatments
10 Jan 2025 //
PR NEWSWIRE